Search results for the

We are consulting on changes to our standards for prescribing until Friday 4 January 2019 and we are keen to hear your views

This policy statement sets out our broad approach to developing memorandums of understanding (MoUs) with other organisations.

We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).

One of registrants’ biggest challenges can be finding time for CPD in an overcrowded schedule.

How to inform us of changes or developments, and what to consider when you do. 

This annual report contains statistical information, analysis on sector developments, key trends and their causes

This annual report contains statistical information, analysis on sector developments, key trends and their causes

We recognise that, due to unavoidable circumstances, some registrants may need to defer (put off) their audit.